Testing the acceptability and feasibility of the lower-risk gambling guidelines in Finland

被引:0
|
作者
Palomaki, Jussi [1 ,2 ]
Latvala, Tiina [1 ]
Salonen, Anne H. [1 ,5 ]
Marionneau, Virve [6 ]
Hodgins, David [7 ]
Young, Matthew M. [8 ,9 ,10 ]
Castren, Sari [1 ,3 ,4 ]
机构
[1] Finnish Inst Hlth & Welf, Dept Publ Hlth & Welf, Helsinki, Finland
[2] Univ Helsinki, Fac Arts, Dept Digital Humanities, Cognit Sci, Helsinki, Finland
[3] Univ Turku, Social Sci Dept Psychol & Speech Language Pathol T, Turku, Finland
[4] Univ Helsinki, Dept Med, Helsinki, Finland
[5] Univ Eastern Finland, Fac Hlth Sci, Kuopio, Finland
[6] Univ Helsinki, Fac Social Sci, Ctr Res Addict Control & Governance, Helsinki, Finland
[7] Univ Calgary, Dept Psychol, Calgary, AB, Canada
[8] Greo Evidence Insights, Guelph, ON, Canada
[9] Canadian Ctr Subst Use & Addict, Ottawa, ON, Canada
[10] Carleton Univ, Dept Psychol, Ottawa, ON, Canada
关键词
acceptability; feasibility; lower-risk gambling limits; problem gambling; prevention; risk curves; STRATEGIES; HABITS; HARMS;
D O I
10.1556/2006.2024.00065
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The lower risk gambling guidelines (LRGG) represent an evidence-based collaborative effort to provide clear advice to people on the limits of safe gambling consumption. The guidelines are as follows: 1) Gamble no more than 1% of household income per month; and 2) Gamble no more than 4 days per month; and 3) Avoid regularly gambling at more than 2 types of games. Methods: In an online survey study (N = 778), we evaluated the feasibility and acceptability of the LRGG among different subpopulations in Finland. Results: We found that the guidelines were generally evaluated positively as understandable, sensible, clear, and "just right" in terms of their content. There were some notable differences between subpopulations: Individuals who were at risk of gambling problems evaluated the LRGG more negatively than others, while professionals working in the field of gambling prevention were the most optimistic about the guidelines. Thus, increased level of potentially harmful gambling engagement was linked with a somewhat more pessimistic attitude towards the guidelines. On the other hand, those who had not gambled in the past year viewed the guidelines as too permissive compared with those who had gambled, or those working in gambling prevention. Discussion: Overall, our results show clear differences of opinion between the various subpopulations, which appear to be associated with the individuals' level and nature of gambling experience. We conclude that the LRGG can likely be adopted into wider use in Finland.
引用
收藏
页码:987 / 1002
页数:16
相关论文
共 50 条
  • [21] LOWER-RISK BETS ON A RESURGENT BUCK
    KUPFER, A
    FORTUNE, 1989, 119 (08) : 40 - 40
  • [22] The Lower-Risk Cannabis Use Guidelines' (LRCUG) recommendations: How are Canadian cannabis users complying?
    Lee, Chae-Rim
    Lee, Angelica
    Goodman, Samantha
    Hammond, David
    Fischer, Benedikt
    PREVENTIVE MEDICINE REPORTS, 2020, 20
  • [23] Trends in Lower-Risk Gambling by Age and Net Income among Finnish Men and Women in 2011, 2015, and 2019
    Gronroos, Tanja
    Kontto, Jukka
    Young, Matthew M.
    Hodgins, David C.
    Salonen, Anne H.
    JOURNAL OF GAMBLING STUDIES, 2025, 41 (01) : 267 - 281
  • [24] How to manage lower-risk myelodysplastic syndromes
    Sekeres, M. A.
    LEUKEMIA, 2012, 26 (03) : 390 - 394
  • [25] Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome
    Battaglia, Muriel R.
    Cannova, Joseph
    Madero-Marroquin, Rafael
    Patel, Anand A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (06) : 752 - 768
  • [26] Lowering the boom on lower-risk myelodysplastic syndromes
    Sekeres, Mikkael A.
    Patel, Bhumika J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 367 - 372
  • [27] Are vaporizers a lower-risk alternative to smoking cannabis?
    Chaiton, Michael
    Kundu, Anasua
    Rueda, Sergio
    Di Ciano, Patricia
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2022, 113 (02): : 293 - 296
  • [28] Evolving therapies for lower-risk myelodysplastic syndromes
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    ANNALS OF HEMATOLOGY, 2020, 99 (04) : 677 - 692
  • [29] VisionAire delays Vantage for lower-risk construction
    Aviat Week Space Technol (New York), 19 (42):
  • [30] Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
    Fenaux, Pierre
    Platzbecker, Uwe
    Mufti, Ghulam J.
    Garcia-Manero, Guillermo
    Buckstein, Rena
    Santini, Valeria
    Diez-Campelo, Maria
    Finelli, Carlo
    Cazzola, Mario
    Ilhan, Osman
    Sekeres, Mikkael A.
    Falantes, Jose F.
    Arrizabalaga, Beatriz
    Salvi, Flavia
    Giai, Valentina
    Vyas, Paresh
    Bowen, David
    Selleslag, Dominik
    DeZern, Amy E.
    Jurcic, Joseph G.
    Germing, Ulrich
    Goetze, Katharina S.
    Quesnel, Bruno
    Beyne-Rauzy, Odile
    Cluzeau, Thomas
    Voso, Maria-Teresa
    Mazure, Dominiek
    Vellenga, Edo
    Greenberg, Peter L.
    Hellstrom-Lindberg, Eva
    Zeidan, Amer M.
    Ades, Lionel
    Verma, Amit
    Savona, Michael R.
    Laadem, Abderrahmane
    Benzohra, Aziz
    Zhang, Jennie
    Rampersad, Anita
    Dunshee, Diana R.
    Linde, Peter G.
    Sherman, Matthew L.
    Komrokji, Rami S.
    List, Alan F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02): : 140 - 151